Dergiler / Klinik Psikofarmakoloji Bülteni / 2016 / Cilt: 26 - Sayı: 2

Hyperprolactinemia is a Major Problem in Patients Treated with Antipsychotic Drugs

Sayfa
210–210
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

DENİZ, F., BASKOY, K., AY, S. A., YONEM, A. (2022). Hyperprolactinemia is a Major Problem in Patients Treated with Antipsychotic Drugs. Klinik Psikofarmakoloji Bülteni, Cilt: 26 - Sayı: 2, 210–210. https://ajindex.com/articles/573921

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Ates MA, Tutuncu R, Oner I, Ercan S, Basoglu C, Algul A, et al. Relationship between plasma levels of prolactin and the severity of negative symptoms in patients with schizophrenia. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 2015;25(1):27-37. [CrossRef] 2. Dilbaz N, Guz H, Arikazan M. Serum gonadal sex hormones early-onset and adult onset schizophrenics: a controlled study. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 1998;8(2):94-9. (Turkish) 3. Melmed S, Kleinberg K, Ho K. Pituitary Physiology and Diagnostic Evaluation. In: Melmed S, Polonsky KS, (editors). Williams textbook of endocrinology. Philadelphia, PA: Elsevier Saunders; 2011. p. 184-186. [CrossRef] 4. Shimatsu A, Hattori N. Macroprolactinemia: diagnostic, clinical, and pathogenic significance. Clin Dev Immunol 2012;2012:167132. [CrossRef] 5. Molitch ME. Medication-induced hyperprolactinemia. Mayo Clin Proc 2005;80(8):1050-7. [CrossRef]